The reduction of concomitant glucocorticoids dosage following treatment with IL-1 receptor antagonist in adult onset Still’s disease. A systematic review and meta-analysis of observational studies

BACKGROUND: Despite being burdened by significant adverse events, glucocorticoids (GCs) are frequently employed in managing adult onset Still’s disease (AOSD), prompting the need for GC-sparing agents. In this work, we performed a systematic review and meta-analysis to synthesize the evidence about...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruscitti, Piero, Ursini, Francesco, Sota, Jurgen, De Giorgio, Roberto, Cantarini, Luca, Giacomelli, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301658/
https://www.ncbi.nlm.nih.gov/pubmed/32595777
http://dx.doi.org/10.1177/1759720X20933133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301658/
https://www.ncbi.nlm.nih.gov/pubmed/32595777
http://dx.doi.org/10.1177/1759720X20933133

Ejemplares similares